ABCC7 p.Ser737Asp

[switch to full view]
Comments [show]
Publications
PMID: 19095655 [PubMed] Kongsuphol P et al: "Mechanistic insight into control of CFTR by AMPK."
No. Sentence Comment
43 EXPERIMENTAL PROCEDURES cRNAs for CFTR and Double Electrode Voltage Clamp-Oocytes were injected with cRNA (10 ng, 47 nl of double-distilled water) encoding wtCFTR, L1430A/L1431A, S573A, S1248A, F508del-CFTR, G551D-CFTR, S768A, S737A, S768D, S737D, E1474X, and AMPK␣1.
X
ABCC7 p.Ser737Asp 19095655:43:241
status: NEW
Login to comment

129 In contrast, the S768D mutation, mimicking phosphorylation at Ser768 , produced a whole cell conductance that was significantly smaller than even wtCFTR (note that conductance not lowered with S737D; see also Fig. 3C for phenformin sensitivity of these mutants).
X
ABCC7 p.Ser737Asp 19095655:129:193
status: NEW
Login to comment

147 In contrast the residual CFTR conductances generated by S768D (but not S737D) were not only further inhibited by phenformin, but neither phospho-mimic mutant could be augmented by the AMPK inhibitor compound C.
X
ABCC7 p.Ser737Asp 19095655:147:71
status: NEW
Login to comment

PMID: 21059651 [PubMed] Wang G et al: "The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator."
No. Sentence Comment
181 It is reasonable that Ser737 may not form an inhibitory H-bond because S737D was not activated by curcumin even if ATP was added (Fig. 6F), further suggesting that Ser737 may be a weak inhibitory site.
X
ABCC7 p.Ser737Asp 21059651:181:71
status: NEW
Login to comment

192 It is reasonable that both Q958R/S737R and Q958D/S737D were not activated by ATP because Ser737 was a weak inhibitory site (Fig. 7C).
X
ABCC7 p.Ser737Asp 21059651:192:49
status: NEW
Login to comment

PMID: 9463368 [PubMed] Sugita M et al: "CFTR Cl- channel and CFTR-associated ATP channel: distinct pores regulated by common gates."
No. Sentence Comment
142 To examine this further, we expressed CFTR S-oct-D, which contains eight serine-to-aspartate substitutions in the R domain (S660D, S686D, S700D, S712D, S737D, S768D, S795D and S813D) (Figure 8A).
X
ABCC7 p.Ser737Asp 9463368:142:152
status: NEW
Login to comment

150 To examine this further, we expressed CFTR S-oct-D, which contains eight serine-to-aspartate substitutions in the R domain (S660D, S686D, S700D, S712D, S737D, S768D, S795D and S813D) (Figure 8A).
X
ABCC7 p.Ser737Asp 9463368:150:152
status: NEW
Login to comment

PMID: 7690753 [PubMed] Rich DP et al: "Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain."
No. Sentence Comment
121 The single-channel open-stateprobabil- ity for wild-type CFTR (n = 14), CFTR S-Quad-A (S600A,S737A, S712A,S737A,S768A,S795A,S813A) (n = 7), or CFTR S-Oct-D (S660D,S686D,S700D,S712D,S737D,S768D,S795D,S813D)(n = 7in ATP alone (-PKA);n = 10 inPKA and ATP (+PkX))C1-channels was determined as described under "Experimental Procedures."
X
ABCC7 p.Ser737Asp 7690753:121:181
status: NEW
Login to comment

123 S795A,S813A) (n = 5).
X
ABCC7 p.Ser737Asp 7690753:123:181
status: NEW
Login to comment

205 Functional analysisof serine-to-aspartate mutantsof CFTR.A, the changes in SPQ fluorescence ofHeLa cells expressing wild-type CFTR (n = 56), CFTR S-Quad-D (S600D,S737D, S795D,S813D) (n = 24), CFTR S-Hex-D (S660D,S686D,S700D, S712D,S737D,S768D,S795D,S813D)( n = 23), or virus only-infected control cells (n = 53) after substitution of NO; for Iat 0 min.
X
ABCC7 p.Ser737Asp 7690753:205:162
status: NEW
X
ABCC7 p.Ser737Asp 7690753:205:231
status: NEW
Login to comment

209 B, time course of current changes inan excised, inside-outmembrane patchfrom a HeLa cell expressingCFTR S-Oct-D (S660D,S686D,S700D,S712D,S737D,S768D,S795D,S813D) C1- chan- nels.ATP (0.88 mM)and PKA (75 m)were added tothe cytosolic(bath) side of the membrane as indicated by the burs.
X
ABCC7 p.Ser737Asp 7690753:209:137
status: NEW
X
ABCC7 p.Ser737Asp 7690753:209:164
status: NEW
X
ABCC7 p.Ser737Asp 7690753:209:233
status: NEW
Login to comment

213 S737D,S795D,S813D) (n = 37), CFTR S-Oct-D (S660D,S686D,S700D, vitro or in vivo (Figs.6 and 9).
X
ABCC7 p.Ser737Asp 7690753:213:0
status: NEW
X
ABCC7 p.Ser737Asp 7690753:213:137
status: NEW
Login to comment

217 S737D,S795D,S813D) (n = 37), CFTR S-Oct-D (S660D,S686D,S700D, vitro or in vivo (Figs.6 and 9).
X
ABCC7 p.Ser737Asp 7690753:217:0
status: NEW
Login to comment